Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Clinical trial NCT02476955 · TERMINATED

Trial details

NCT number: NCT02476955
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Ovarian Cancer Endometrial Cancer

Start date: 2015-06-09
Primary completion: 2019-05-07
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.